CClinicalTrials.gg
CompletedNCT03964077Updated Jan 28, 2020

Turkish Version of the Neurogenic Bladder Symptom Score Questionnaire: a Cross-cultural Adaptation, Reliability and Validity Study

An observational study in Spinal Cord Injuries, sponsored by Gaziosmanpasa Research and Education Hospital. Completed at 1 site in Turkey. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2020-01-28.

Sponsored by Gaziosmanpasa Research and Education Hospital · Observational

Study type
Observational
Model
Case-control
Time perspective
Cross-sectional
Enrollment
102
Ages
18 Years and older
Sex
All
01

Study summary

Turkish version of the Neurogenic Bladder Symptom Score questionnaire: a cross-cultural adaptation, reliability and validity study

Read the detailed description

Turkish version of the Neurogenic Bladder Symptom Score questionnaire: a cross-cultural adaptation, reliability and validity study in spinal cord patients.

02

Conditions studied

  • Spinal Cord Injuries

Keywords

  • Neurogenic Bladder
  • Quality of life
  • Spinal Cord Injury
03

In context

Spinal Cord Injuries

1,948 studies on the registry are indexed under Spinal Cord Injuries; 505 are open to participants now.

This study's enrollment of 102 is above the median of 60 across 323 observational studies indexed under Spinal Cord Injuries.

Browse Spinal Cord Injuries studies →

Lead sponsor

Gaziosmanpasa Research and Education Hospital is the lead sponsor of 122 studies on the registry; 29 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

70 spinal cord injury patients

Inclusion criteria

  • Spinal cord injury patients
  • aged > 18 years old

Exclusion criteria

Exclusion Criteria:

  • spinal shock patients
  • urinary tract operation in the last month
  • Quality of life changes in the last month
  • urinary tract infections in the last month
  • bladder management changes or drug changes in the last month
05

Study design

Observational model
Case-control
Time perspective
Cross-sectional
Enrollment
102 participants (actual)
Patient registry
No

Interventions

  • Diagnostic testNeurogenic Bladder Symptom Score Questionnaire

    Neurogenic Bladder Symptom Score Questionnaire is a self-reported 24 item questionnaire.

06

What researchers measure

Primary outcomes

  1. Life quality: Short-form 36

    The quality of life of the patients will be determined using Short-form 36. The self-reported questionnaire includes 8 domains (using algorithms) (0-100 points). Higher scores show poorer quality of life.

    Time frame: 4 months

  2. Neurogenic Bladder Symptom Score Questionnaire

    Neurogenic Bladder Symptom Score Questionnaire is a 24 item self-reported questionnaire(0-74 points). The questionnaire includes 4 subgroups; incontinence (0-29 points), storage\&voiding (0-22 points) and consequences (0-23 points). Higher the score, the greater the severity of the symptoms.

    Time frame: 4 months

  3. The King's Health Questionnaire

    The King's Health Questionnaire (KHQ) is one of the most widely used for assessing QOL in patients with urinary inkontinence.The KHQ consists of two parts and 32 items \[7\]. The first part (21 items) contains two single-item questions that address General Health Perception and Incontinence Impact and the following seven multi-item domains: Role, Physical, and Social Limitations, Limitations in Personal Relationship, Emotional Problems, Sleep and Energy Disturbances associated with UI, and Severity Measures for UI. The second part has an 11-item Symptom Severity Scale (SSS) that assesses the presence and severity of urinary symptoms. While the entire SSS is scored from 0 (best) to 30 (worst), the minimum possible score is 0 (best health) and the maximum possible score is 100 (worst health) for all other KHQ domains.

    Time frame: 4 months

07

Study locations

1 site
  • Mehmet Akif Guler
    İstanbul, İ̇stanbul 34104, Turkey
08

References and documents

Publications

  • Guler MA, Dogan D, Yilmaz Yalcinkaya E. Validity and reliability of the Turkish version of the neurogenic bladder symptom score. Disabil Rehabil. 2022 Jun;44(12):2889-2895. doi: 10.1080/09638288.2020.1846216. Epub 2020 Nov 24. PubMed 33232613 ↗

Individual participant data

Plan to share: Undecided

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 28, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03964077
Lead sponsor
Gaziosmanpasa Research and Education Hospital
Responsible party
Mehmet Akif GÜLER (Principal Investigator, Gaziosmanpasa Research and Education Hospital) — Principal investigator
First posted
May 28, 2019
Start date
Jun 1, 2019
Primary completion
Jan 27, 2020
Completion
Jan 27, 2020
Last update
Jan 28, 2020

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion